chr1-39901199-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001033081.3(MYCL):c.236C>T(p.Ser79Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001033081.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYCL | NM_001033081.3 | c.236C>T | p.Ser79Leu | missense_variant | 1/2 | ENST00000372816.3 | |
MYCL | NM_001033082.3 | c.326C>T | p.Ser109Leu | missense_variant | 2/3 | ||
MYCL | NM_005376.5 | c.326C>T | p.Ser109Leu | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYCL | ENST00000372816.3 | c.236C>T | p.Ser79Leu | missense_variant | 1/2 | 2 | NM_001033081.3 | P4 | |
MYCL | ENST00000397332.3 | c.326C>T | p.Ser109Leu | missense_variant | 2/3 | 1 | A1 | ||
MYCL | ENST00000372815.1 | c.326C>T | p.Ser109Leu | missense_variant | 2/2 | 1 | |||
MYCL | ENST00000450953.3 | c.236C>T | p.Ser79Leu | missense_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460826Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726694
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The c.326C>T (p.S109L) alteration is located in exon 2 (coding exon 2) of the MYCL gene. This alteration results from a C to T substitution at nucleotide position 326, causing the serine (S) at amino acid position 109 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at